Cargando…
Identification and Validation of an Immune and Ferroptosis-Combined Index for Non–Small Cell Lung Cancer
Background: Non–small cell lung cancer (NSCLC) is among the major health problems around the world. Reliable biomarkers for NSCLC are still needed in clinical practice. We aimed to develop a novel ferroptosis- and immune-based index for NSCLC. Methods: The training and testing datasets were obtained...
Autores principales: | Teng, Yang, Wang, Bo, Shang, Desi, Yang, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669617/ https://www.ncbi.nlm.nih.gov/pubmed/34917129 http://dx.doi.org/10.3389/fgene.2021.764869 |
Ejemplares similares
-
Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma
por: Zheng, Zhiyuan, et al.
Publicado: (2021) -
Identification and validation of ferroptosis-related genes and immune cell infiltration in thyroid associated ophthalmopathy
por: Chen, Sainan, et al.
Publicado: (2023) -
Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma
por: Zhou, Zhongbao, et al.
Publicado: (2022) -
Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
por: Lai, Li-Ting, et al.
Publicado: (2023) -
Identification and Validation of Ferroptosis-Related Biomarkers in Septic Cardiomyopathy via Bioinformatics Analysis
por: Gong, Cheng-Wu, et al.
Publicado: (2022)